Zydus Lifesciences has informed the stock exchanges that the company and its various subsidiaries have invested the remaining Rs 90.18 million in Torrent Urja 25 under Tranches 2, 3 and 4 of the previously executed Share Subscription and Shareholders’ Agreements (SSSAs).

The company stated that the investment was completed on May 19, 2026, through the subscription of 90,17,848 equity shares of Torrent Urja 25, representing 22.06 percent of its paid-up share capital.

The company further noted that this follows its earlier investment of Rs 38.65 million made in June 2025 under Tranche 1, when the company and its subsidiaries subscribed to 38,64,792 equity shares of Torrent Urja 25.

With the completion of the latest investment, the transaction for subscription of shares in Torrent Urja 25 has now been fully consummated, the company said in its regulatory filing.